We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPS icon
8526
PUT
Digital Turbine
APPS
$1.51B
$52K ﹤0.01%
10,300
-900
-8% -$3.62K
ROYT
8527
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$52K ﹤0.01%
23,536
-15,833
-40% -$34.6K
AMBO
8528
Ambow Education Holding
AMBO
$6.09M
$51K ﹤0.01%
+1,366
New +$63.6K
CIG icon
8529
CALL
CEMIG Preferred Shares
CIG
$5.52B
$51K ﹤0.01%
+26,484
New +$48.7K
INO icon
8530
CALL
Inovio Pharmaceuticals
INO
$113M
$51K ﹤0.01%
1,458
-134
-8% -$5.32K
REPX icon
8531
Riley Exploration Permian
REPX
$800M
$51K ﹤0.01%
5,066
+1,109
+28% +$13.1K
RMTI icon
8532
PUT
Rockwell Medical
RMTI
$29.2M
$51K ﹤0.01%
155
-58
-27% -$29.5K
JNCE
8533
CALL
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$51K ﹤0.01%
+10,400
New +$55.2K
EMWP
8534
CALL
DELISTED
Eros Media World PLC
EMWP
$51K ﹤0.01%
1,895
-265
-12% -$35.7K
RBZ
8535
DELISTED
Reebonz Holding Limited Ordinary Shares
RBZ
$51K ﹤0.01%
+13,629
New +$83.6K
LXU icon
8536
LSB Industries
LXU
$737M
$50K ﹤0.01%
+16,650
New +$63.5K
VIVO
8537
VivoPower PLC
VIVO
$150M
$50K ﹤0.01%
+3,545
New +$43.6K
DYNT
8538
DELISTED
Dynatronics Corp
DYNT
$50K ﹤0.01%
6,009
+2,582
+75% +$22.1K
TTPH
8539
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$50K ﹤0.01%
5,213
-69
-1% -$1.27K
SDRL
8540
CALL
DELISTED
Seadrill Limited Common Stock
SDRL
$50K ﹤0.01%
+11,900
New +$78.2K
ACHN
8541
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$50K ﹤0.01%
+18,600
New +$54.9K
KZIA
8542
Kazia Therapeutics
KZIA
$154M
$49K ﹤0.01%
+409
New +$62.9K
CYAN
8543
DELISTED
Cyanotech Corp
CYAN
$49K ﹤0.01%
+15,811
New +$50.3K
IMGN
8544
PUT
DELISTED
Immunogen Inc
IMGN
$49K ﹤0.01%
22,500
-75,500
-77% -$179K
AIRI icon
8545
Air Industries Group
AIRI
$12.3M
$48K ﹤0.01%
4,406
-316
-7% -$3.46K
LYG icon
8546
PUT
Lloyds Banking Group
LYG
$90.1B
$48K ﹤0.01%
17,000
-55,100
-76% -$170K
REFR icon
8547
CALL
Research Frontiers
REFR
$15.3M
$48K ﹤0.01%
14,400
-2,500
-15% -$7.08K
TRAW icon
8548
Traws Pharma
TRAW
$8.7M
$48K ﹤0.01%
+45
New +$62K
BLNE
8549
Beeline Holdings
BLNE
$33.2M
$48K ﹤0.01%
+53
New +$55.7K
ELSE
8550
DELISTED
Electro-Sensors
ELSE
$47K ﹤0.01%
+14,260
New +$49.9K

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.